As of 2025-05-15, the Relative Valuation of Guardant Health Inc (GH) is (85.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.72 USD, the upside of Guardant Health Inc based on Relative Valuation is -310.8%.
The range of the Relative Valuation is (86.75) - (75.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.8x - 33.5x | 29.6x |
| Forward P/E multiples | 19.5x - 22.5x | 21.5x |
| Fair Price | (86.75) - (75.78) | (85.82) |
| Upside | -313.0% - -286.1% | -310.8% |
| Date | P/E |
| 2025-05-14 | -12.11 |
| 2025-05-13 | -12.30 |
| 2025-05-12 | -12.39 |
| 2025-05-09 | -12.41 |
| 2025-05-08 | -12.40 |
| 2025-05-07 | -11.82 |
| 2025-05-06 | -12.47 |
| 2025-05-05 | -13.10 |
| 2025-05-02 | -13.93 |
| 2025-05-01 | -14.53 |
| 2025-04-30 | -14.05 |
| 2025-04-29 | -14.73 |
| 2025-04-28 | -14.27 |
| 2025-04-25 | -14.37 |
| 2025-04-24 | -14.10 |
| 2025-04-23 | -13.57 |
| 2025-04-22 | -13.03 |
| 2025-04-21 | -12.67 |
| 2025-04-17 | -13.38 |
| 2025-04-16 | -13.44 |
| 2025-04-15 | -13.34 |
| 2025-04-14 | -13.43 |
| 2025-04-11 | -13.00 |
| 2025-04-10 | -12.24 |
| 2025-04-09 | -13.05 |
| 2025-04-08 | -11.84 |
| 2025-04-07 | -12.43 |
| 2025-04-04 | -12.07 |
| 2025-04-03 | -12.50 |
| 2025-04-02 | -12.93 |
| 2025-04-01 | -12.63 |
| 2025-03-31 | -12.67 |
| 2025-03-28 | -12.83 |
| 2025-03-27 | -13.43 |
| 2025-03-26 | -13.63 |
| 2025-03-25 | -13.82 |
| 2025-03-24 | -13.90 |
| 2025-03-21 | -13.71 |
| 2025-03-20 | -13.30 |
| 2025-03-19 | -13.75 |
| 2025-03-18 | -13.04 |
| 2025-03-17 | -12.76 |
| 2025-03-14 | -12.76 |
| 2025-03-13 | -12.09 |
| 2025-03-12 | -12.82 |
| 2025-03-11 | -12.68 |
| 2025-03-10 | -10.66 |
| 2025-03-07 | -11.69 |
| 2025-03-06 | -11.95 |
| 2025-03-05 | -12.69 |